MikroScore
Science-backed ingredient evidence
Moderate Evidence Safety: Use with caution Study dose: 50 mg/day

Vitamin B3 (Niacin)

Also known as: Niacin, Nicotinsäure, Nicotinamid, Vitamin B3

Summary Moderate Evidence

Vitamin B3 is essential and a NAD+ precursor. While deficiency correction matters, high-dose niacin causes side effects—benefits for aging in healthy adults remain unclear.

EU Health Claims: Approved

In the EU, niacin has approved health claims for energy metabolism, mental function, skin and nervous system support. However, high-dose products may be assessed differently both regulatorily and for safety compared to standard supplements.

AI Summary

Quick verdict

Vitamin B3 is essential and a NAD+ precursor. While deficiency correction matters, high-dose niacin causes side effects—benefits for aging in healthy adults remain unclear.

What the evidence supports

Niacin is established as an essential nutrient and NAD+ precursor. High-dose nicotinic acid modifies blood lipids but carries significant side effects.

What is NOT supported

Long-term safety and rare adverse effects in humans remain insufficiently studied.

EU/EFSA status

Approved. In the EU, niacin has approved health claims for energy metabolism, mental function, skin and ner…

Safety

Use with caution

This AI summary is generated from the structured data on this page.

What is Vitamin B3?

Vitamin B3 comprises primarily nicotinic acid (niacin) and nicotinamide. Both forms are precursors to NAD+, a central coenzyme required for energy production, redox reactions, and numerous cellular processes. This biochemical role makes B3 particularly interesting in longevity circles: since NAD+ declines with age, the hypothesis follows that supplementing its precursors could slow aging.

What is comparatively well established?

  • B3 is an essential nutrient — humans require it for survival
  • Correcting frank B3 deficiency (rare in developed countries) reliably restores function
  • Pharmacological doses of nicotinic acid measurably alter blood lipids, particularly raising HDL and lowering triglycerides
  • NAD+ biochemistry is real and well-characterized

What is comparatively poorly established?

  • Whether increasing NAD+ in healthy, replete individuals translates to health benefits
  • Anti-aging effects of standard or high-dose niacin in humans with normal baseline nutrition
  • Whether pharmacological doses of niacin are preferable to dietary intake or other NAD+ pathway modulators
  • Optimal dose, form, and duration for any longevity claim

The evidence for cardiovascular effects is sobering

Large trials have repeatedly disappointed. The HPS2-THRIVE trial enrolled 25,673 high-risk patients and tested extended-release niacin combined with laropiprant (to reduce flushing). Despite favorable changes in HDL and triglycerides, the trial showed no reduction in cardiovascular events and actually more adverse events in the niacin group.

The lipid effects are real but clinically underwhelming in the modern statin era. Most cardiologists have moved away from niacin monotherapy.

Form matters significantly

Nicotinic acid (niacin):

  • Causes the characteristic “flush”—transient facial redness, warmth, and itching
  • Strongest evidence base for lipid effects
  • More hepatotoxic at high doses
  • Affects glucose metabolism and uric acid levels more than nicotinamide

Nicotinamide:

  • Generally better tolerated (no flush)
  • Different pharmacology—does not raise HDL as effectively
  • Different side effect profile
  • Often preferred in supplements marketed for general wellness

These are not interchangeable. Supplement labels often use “Vitamin B3” without specifying form, creating confusion.

Safety and side effects

High-dose niacin is not a benign supplement:

Common: Flush, gastrointestinal upset, nausea

At pharmacological doses: Elevated liver enzymes, hyperglycemia, elevated uric acid (gout risk), skin rashes

Individual variation: Some people tolerate high doses; others experience pronounced symptoms at much lower amounts

The European Food Safety Authority permits health claims for niacin’s role in energy metabolism and nervous system function—these reflect its essential nutrient status, not anti-aging properties.

What about NAD+ and aging?

The observation that NAD+ declines with age is genuine. Animal models (particularly mice) show that restoring NAD+ can improve mitochondrial function and extend lifespan. But translation to humans is unproven. Clinical trials of NAD+ precursors in aging humans are sparse and generally small.

Niacin’s effects on NAD+ in vivo remain unclear at doses used in supplements. The relationship between blood NAD+ levels (rarely measured clinically) and cellular NAD+ is poorly understood. And whether higher NAD+ causally drives healthspan improvements in humans—when all confounders are controlled—remains speculative.

The longevity hype vs. reality gap

Niacin circulates in anti-aging forums and biohacker communities as a NAD+ booster with supposed effects on cellular senescence, mitochondrial health, and aging slowing. The biochemistry is superficially compelling. But clinical evidence in humans is absent.

If you are severely niacin-deficient (pellagra is now rare), correction is medically necessary. If you have elevated triglycerides and statin intolerance, a trial of high-dose niacin under medical supervision is reasonable—though even then, the benefit is modest.

For a healthy person seeking longevity benefits through niacin supplementation, the evidence-to-hype ratio is poor. The side effects are real. The benefits are speculative.

Conclusion

Vitamin B3 is biochemically essential and interesting, but supplement evidence frequently doesn’t match the enthusiasm of the longevity community. Use it as a baseline micronutrient if you’re at risk of deficiency. Use it as a tool under medical supervision if you have specific lipid issues. Beyond that, the risk-benefit trade-off remains unfavorable until better human evidence emerges.

Key Studies

Niacin in cardiovascular disease: recent preclinical and clinical developments

Guyton JR et al. (2013)

Review: Niacin was associated with lipid marker changes, but clinical added benefit in the modern statin era is limited and side effects are common.

PubMed PMID 23676243

Effects of extended-release niacin with laropiprant in high-risk patients

Landray MJ et al. (2014)

Large trial: Despite favorable effects on HDL and triglycerides, no convincing clinical advantage was demonstrated, with more side effects observed.

PubMed PMID 25014686

Niacin

Bogan KL et al. (2008)

Review of biochemistry and metabolism: Niacin is central to NAD/NADP function and thus to energy and redox metabolism.

PubMed PMID 18454811

Products with Vitamin B3 (Niacin)

No reviewed products yet — we're working on it.

See all reviewed products →
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.